Cost-effectiveness of dengue vaccination in Puerto Rico.
An effective and widely used vaccine could reduce the burden of dengue virus (DENV) around the world. DENV is endemic in Puerto Rico, where the dengue vaccine CYD-TDV is currently under consideration as a control measure. CYD-TDV has demonstrated efficacy in clinical trials in vaccinees who had prio...
Published in: | PLOS Neglected Tropical Diseases |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doi.org/10.1371/journal.pntd.0009606 https://doaj.org/article/2e34002b38d04636b6e0121621a58d7c |
id |
ftdoajarticles:oai:doaj.org/article:2e34002b38d04636b6e0121621a58d7c |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:2e34002b38d04636b6e0121621a58d7c 2023-05-15T15:10:13+02:00 Cost-effectiveness of dengue vaccination in Puerto Rico. Guido España Andrew J Leidner Stephen H Waterman T Alex Perkins 2021-07-01T00:00:00Z https://doi.org/10.1371/journal.pntd.0009606 https://doaj.org/article/2e34002b38d04636b6e0121621a58d7c EN eng Public Library of Science (PLoS) https://doi.org/10.1371/journal.pntd.0009606 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0009606 https://doaj.org/article/2e34002b38d04636b6e0121621a58d7c PLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009606 (2021) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2021 ftdoajarticles https://doi.org/10.1371/journal.pntd.0009606 2022-12-31T16:22:38Z An effective and widely used vaccine could reduce the burden of dengue virus (DENV) around the world. DENV is endemic in Puerto Rico, where the dengue vaccine CYD-TDV is currently under consideration as a control measure. CYD-TDV has demonstrated efficacy in clinical trials in vaccinees who had prior dengue virus infection. However, in vaccinees who had no prior dengue virus infection, the vaccine had a modestly elevated risk of hospitalization and severe disease. The WHO therefore recommended a strategy of pre-vaccination screening and vaccination of seropositive persons. To estimate the cost-effectiveness and benefits of this intervention (i.e., screening and vaccination of seropositive persons) in Puerto Rico, we simulated 10 years of the intervention in 9-year-olds using an agent-based model. Across the entire population, we found that 5.5% (4.6%-6.3%) of dengue hospitalizations could be averted. However, we also found that 0.057 (0.045-0.073) additional hospitalizations could occur for every 1,000 people in Puerto Rico due to DENV-naïve children who were vaccinated following a false-positive test results for prior exposure. The ratio of the averted hospitalizations among all vaccinees to additional hospitalizations among DENV-naïve vaccinees was estimated to be 19 (13-24). At a base case cost of vaccination of 382 USD, we found an incremental cost-effectiveness ratio of 122,000 USD per QALY gained. Our estimates can provide information for considerations to introduce the CYD-TDV vaccine in Puerto Rico. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic PLOS Neglected Tropical Diseases 15 7 e0009606 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Guido España Andrew J Leidner Stephen H Waterman T Alex Perkins Cost-effectiveness of dengue vaccination in Puerto Rico. |
topic_facet |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
An effective and widely used vaccine could reduce the burden of dengue virus (DENV) around the world. DENV is endemic in Puerto Rico, where the dengue vaccine CYD-TDV is currently under consideration as a control measure. CYD-TDV has demonstrated efficacy in clinical trials in vaccinees who had prior dengue virus infection. However, in vaccinees who had no prior dengue virus infection, the vaccine had a modestly elevated risk of hospitalization and severe disease. The WHO therefore recommended a strategy of pre-vaccination screening and vaccination of seropositive persons. To estimate the cost-effectiveness and benefits of this intervention (i.e., screening and vaccination of seropositive persons) in Puerto Rico, we simulated 10 years of the intervention in 9-year-olds using an agent-based model. Across the entire population, we found that 5.5% (4.6%-6.3%) of dengue hospitalizations could be averted. However, we also found that 0.057 (0.045-0.073) additional hospitalizations could occur for every 1,000 people in Puerto Rico due to DENV-naïve children who were vaccinated following a false-positive test results for prior exposure. The ratio of the averted hospitalizations among all vaccinees to additional hospitalizations among DENV-naïve vaccinees was estimated to be 19 (13-24). At a base case cost of vaccination of 382 USD, we found an incremental cost-effectiveness ratio of 122,000 USD per QALY gained. Our estimates can provide information for considerations to introduce the CYD-TDV vaccine in Puerto Rico. |
format |
Article in Journal/Newspaper |
author |
Guido España Andrew J Leidner Stephen H Waterman T Alex Perkins |
author_facet |
Guido España Andrew J Leidner Stephen H Waterman T Alex Perkins |
author_sort |
Guido España |
title |
Cost-effectiveness of dengue vaccination in Puerto Rico. |
title_short |
Cost-effectiveness of dengue vaccination in Puerto Rico. |
title_full |
Cost-effectiveness of dengue vaccination in Puerto Rico. |
title_fullStr |
Cost-effectiveness of dengue vaccination in Puerto Rico. |
title_full_unstemmed |
Cost-effectiveness of dengue vaccination in Puerto Rico. |
title_sort |
cost-effectiveness of dengue vaccination in puerto rico. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doi.org/10.1371/journal.pntd.0009606 https://doaj.org/article/2e34002b38d04636b6e0121621a58d7c |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
PLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009606 (2021) |
op_relation |
https://doi.org/10.1371/journal.pntd.0009606 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0009606 https://doaj.org/article/2e34002b38d04636b6e0121621a58d7c |
op_doi |
https://doi.org/10.1371/journal.pntd.0009606 |
container_title |
PLOS Neglected Tropical Diseases |
container_volume |
15 |
container_issue |
7 |
container_start_page |
e0009606 |
_version_ |
1766341252304863232 |